The study shows that a hormone called thymosin‑alpha‑1 can protect mouse immune cells (thymocytes) from dying when exposed to harmful factors found in the blood of tumor‑bearing mice. It works by tweaking cell‑signaling pathways that control death‑related proteins, lowering the levels of proteins that promote cell death and raising those that prevent it. However, the research is done in mice, uses tumor serum, and doesn’t give dosage or human data, so its direct use for everyday health hacks is limited.
In mice, the peptide thymosin‑alpha‑1 helped bone‑marrow cells grow and form more blood‑cell colonies, even when the animals had a T‑cell lymphoma that normally suppresses bone‑marrow activity. A single injection (10 µg per mouse) or a lab dose of 100 ng/ml gave the biggest boost, especially when combined with other growth factors.
Scientists discovered that the peptide thymosin‑alpha‑1 is naturally made in certain brain and spinal‑cord cells of rats and that brain cells can also take it up, hinting it might play a role in nervous‑system function.
Mutchnick. M G MG; Lindsay. K L KL; Schiff. E R ER; Cummings. G D GD; Appelman. H D HD; Peleman. R R...
A Phase III trial gave thymosin‑alpha‑1 (1.6 mg twice a week for 6 months) to people with chronic hepatitis B and compared it to a placebo. The drug showed a slightly higher chance of clearing the virus, but the differences weren’t statistically solid, so the study can’t prove it works better than nothing.
Moody. Terry W TW; Tuthill. Cynthia C; Badamchian. Mahnaz M; Goldstein. Allan L AL
In a rat study, giving a tiny daily dose of the peptide thymosin‑alpha‑1 under the skin lowered the number of breast cancers that developed after a chemical trigger and helped the animals live longer, likely by boosting their white blood cells.
The paper reviews how adding the peptide thymosin‑alpha‑1 to low‑dose interferon, interleukin‑2, or chemotherapy can boost the immune system’s fight against cancer and lower side‑effects, but it doesn’t give specific dosing or home‑use instructions.
Lau. G K K GK; Nanji. A A; Hou. J J; Fong. D Y T DY; Au. W-S WS; Yuen. S-T ST; Lin. M M; Kung. H-F H...
A study gave people with chronic hepatitis B a peptide called thymosin‑alpha1 together with an antiviral drug. The combo lowered the virus a bit more than the drug alone and a few patients even cleared a key viral marker, while side effects stayed low. This hints the peptide can boost immune cells, but the benefit was modest and only shown in sick patients, not healthy folks.
In mice, giving thymosin‑alpha‑1 under the skin for a week boosted immune cell numbers and cut down the spread and growth of injected cancer cells in the liver, lungs, and under the skin. The study shows the peptide can enhance the immune system and slow tumor growth, but it’s only animal data and the doses used are far from what humans would take.
Pozo. D D; Guerrero. J M JM; Segura. J J JJ; Calvo. J R JR
Thymosin‑alpha‑1 can bind to the same receptors that VIP uses, but it does so much weaker—about a thousand times less potent—so it acts mostly as a very weak blocker rather than a strong activator.
Knutsen. A P AP; Freeman. J J JJ; Mueller. K R KR; Roodman. S T ST; Bouhasin. J D JD
In a lab test, adding the peptide thymosin‑alpha1 to human stem cells grown with thymus tissue helped the cells multiply and turn into mature CD4+ T‑cells, which are important for immune function. The study was done entirely in a dish, so it doesn’t tell us how to use the peptide in people, but it shows the peptide can boost T‑cell development under these conditions.
Baumann. C A CA; Badamchian. M M; Goldstein. A L AL
This mouse study shows that the peptide thymosin‑alpha‑1 can protect young immune cells in the thymus from dying when they’re exposed to stress hormones like dexamethasone or signals that normally trigger cell death. It does this by boosting internal signals (cAMP and PKC) that help the cells survive.
Moshier. J A JA; Mutchnick. M G MG; Dosescu. J J; Holtz. T K TK; Akkary. S S; Mahakala. K K; Merline...
The study shows that thymosin‑alpha‑1 can slow down the growth of liver cancer‑like cells that carry hepatitis B virus in a lab dish, but it doesn’t affect normal liver cells. It works better when combined with interferon‑alpha, though the effect is still modest. These results are from cell experiments, not human trials, so they’re not ready to be turned into a treatment plan yet.
Moody. T W TW; Leyton. J J; Zia. F F; Tuthill. C C; Badamchian. M M; Goldstein. A L AL
In a mouse study, daily injections of thymosin‑alpha‑1 reduced early lung tumor numbers by up to about 45% and increased white‑blood‑cell density, indicating an immune‑related protective effect.
Qiu. Longxin L; Zhang. Cuilin C; Zhang. Jun J; Liang. Jiaxin J; Liu. Jun J; Ji. Cishu C; Yang. James...
In mice that were given a chemical that causes diabetes, giving the peptide thymosin‑alpha‑1 alongside it lowered blood sugar, raised insulin a bit, and protected the pancreas from damage, likely by boosting antioxidant defenses.
Tang. J H JH; Yeh. C T CT; Chen. T C TC; Hsieh. S Y SY; Chu. C M CM; Liaw. Y F YF
In a hepatitis B patient treated with the immune‑boosting peptide thymosin‑alpha‑1, the virus changed its surface protein so standard tests missed it, even though the infection stayed active. The changes were caused by two tiny amino‑acid swaps and weren’t in the main part of the protein that the immune system usually targets, hinting that the drug’s immune‑stimulating effect may push the virus to mutate.
Silecchia. G G; Guarino. E E; Sinibaldi-Vallebona. P P; Pierimarchi. P P; Restuccia. A A; Spaziani....
In a rat study of colon‑cancer spread to the liver, giving two rounds of a combo treatment—chemotherapy drug 5‑fluorouracil plus the immune peptides thymosin‑alpha‑1 and interleukin‑2—kept the animals alive longer than one round or chemo alone, and even cured two rats. The combo also boosted certain immune cells and cut down extra‑liver tumors.
A 47‑year‑old kidney‑transplant patient who got a rare stomach fungal infection (mucormycosis) and a CMV lung infection was treated with antifungal drugs, ganciclovir, and the immune‑boosting peptide thymosin‑alpha‑1 while lowering her immunosuppressant dose. She started improving after two weeks and left the hospital after about three months.
Ohmori. H H; Kamo. M M; Yamakoshi. K K; Nitta. M H MH; Hikida. M M; Kanayama. N N
In mice whose immune systems were weakened by a chemotherapy drug, giving the peptide thymosin‑alpha‑1 helped their T‑cells and killer cells bounce back faster. The study shows the peptide can boost both the humoral (antibody) and cellular parts of immunity, but it’s all in animal models, not humans.
Koutrafouri. V V; Leondiadis. L L; Avgoustakis. K K; Livaniou. E E; Czarnecki. J J; Ithakissios. D S...
The study shows that thymosin alpha‑1 (Tα1) can boost new blood‑vessel growth in a chick embryo model, while some other thymosin peptides block this process. This suggests Tα1 might help with tissue repair, but the work is early‑stage and done in animals, not humans.
Turrini. Paolo P; Tirassa. Paola P; Vigneti. Eliana E; Aloe. Luigi L
In baby rats, removing the thymus lowered a brain protein called NGF that supports nerve cells, and a hormone from the thymus called thymosin‑alpha‑1 partly restored those levels when injected into the brain. This shows the thymus may help regulate brain health factors, but the work is early‑stage and done in animals.